PMR. Pharmaceutical, Healthcare and Medical Sector in Central and Eastern Europe: Industry News, Analyses and Market Data. «Archived copy». Αρχειοθετήθηκε από το πρωτότυπο στις 28 Ιουλίου 2012. Ανακτήθηκε στις 13 Ιουνίου 2012. (accessed 17 May 2012).
Evaluate Pharma. «Archived copy». Αρχειοθετήθηκε από το πρωτότυπο στις 17 Δεκεμβρίου 2012. Ανακτήθηκε στις 13 Ιουνίου 2012. (accessed 17 May 2012).
PMR. Pharmaceutical, Healthcare and Medical Sector in Central and Eastern Europe: Industry News, Analyses and Market Data. «Archived copy». Αρχειοθετήθηκε από το πρωτότυπο στις 28 Ιουλίου 2012. Ανακτήθηκε στις 13 Ιουνίου 2012. (accessed 17 May 2012).
«Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics».J. Cardiovasc. Pharmacol.47(3): 493–9.March 2006.doi:10.1097/01.fjc.0000211732.76668.d2.PMID16633095.
«Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction».J. Cardiovasc. Pharmacol.48(6): 314–9.December 2006.doi:10.1097/01.fjc.0000250077.07702.23.PMID17204911.
«Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction».Eur. J. Pharmacol.395(3): 217–24.May 2000.doi:10.1016/S0014-2999(00)00098-4.PMID10812052.
«Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics».J. Cardiovasc. Pharmacol.47(3): 493–9.March 2006.doi:10.1097/01.fjc.0000211732.76668.d2.PMID16633095.
«Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction».J. Cardiovasc. Pharmacol.48(6): 314–9.December 2006.doi:10.1097/01.fjc.0000250077.07702.23.PMID17204911.
«Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction».Eur. J. Pharmacol.395(3): 217–24.May 2000.doi:10.1016/S0014-2999(00)00098-4.PMID10812052.